News & Videos - INVICTUS MD STRATEGIES IVITF

Vancouver, British Columbia--(Newsfile Corp. - February 25, 2020) - INVICTUS MD STRATEGIES CORP. (TSXV: GENE) (OTCQX: IVITF) ( FSE: 8IS2) (the " Company ") announces that on Monday, February 24, 2020, the Supreme Court of British Columbia (the " Court ") granted an amended and restated initial order (the " Amended and Restated Initial Order ") under the Companies' Creditors Arrangement Act (Canada) (" CCAA "). The Amended and Restated Initial Order also extends protection to Greener Pastures MD...

Vancouver, B.C., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the “ Company ”) announced that on Thursday, February 13, 2020, the Supreme Court of British Columbia (the “ Court ”) issued an order granting the Company’s application for creditor protection under the Companies’ Creditors Arrangement Act (Canada) (“ CCAA ”). The order also extends protection to Greener Pastures MD Ltd., Acreage Pharms Ltd. (“ Acreage ”),...

Vancouver, B.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Vancouver, BC, January 3, 2020 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) further to the Company’s news release dated December 16, 2019, the Company has terminated the binding letter of intent with Unified Cannabis Corp. of Calgary, Alberta in respect of the proposed $5.7 million convertible debenture financing. For more information, please visit www.invictus-md.com. Marc Ripa Interim...

Vancouver, B.C., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 16, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to announce that it has signed a binding letter of intent dated December 11, 2019 with Unified Cannabis Corp. of Calgary, Alberta (“ Unified ”) pursuant to which Unified, subject to acceptance by the TSX Venture Exchange (the “ Exchange ”), has agreed, by way of a non-brokered private placement...

Vancouver, B.C., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 13, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Trevor Dixon has resigned from the Board of Directors of the Company effective immediately. Marc Ripa has been appointed to the Board to fill the casual vacancy. Mr. Ripa stated, “On behalf of the Board, we wish to thank Trevor for his service as both a Director and Officer of the Company and...

Vancouver, B.C., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Messrs. Sparkes and Stein have resigned from the Board of Directors of the Company effective December 5, 2019. For more information, please visit www.invictus-md.com. Marc Ripa Interim Chief Executive Officer Investor Relations 1-844-800-6086 E-Mail: [email protected] Neither the TSX...

Vancouver, B.C., Dec. 02, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that Trevor Dixon is returning to the Board of Directors of the Company, his health issues having been resolved, effective today. Mr. Dixon thanks Brenda Dixon for being his alternate Director while he was on medical leave. Ms. Dixon continues her position as a Director and Quality Assurance Person of Acreage Pharms Ltd., a wholly owned...

Vancouver, B.C., Nov. 25, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2 ) the Company is pleased to announce the completion, effective September 30, 2019, of the previously announced termination of its license agreement with ABG-HMX, LLC pursuant to an omnibus settlement and termination agreement (the “ Agreement ”). The Company sought and received regulatory approval from the TSX Venture Exchange to complete the...

Vancouver, B.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and Chief Operating Officer of Invictus, is pleased to report that the Company’s wholly owned subsidiary Acreage Pharms Ltd. (“ Acreage Pharms ”) has hired Kris Love as Vice-President of Production effective August 1, 2019. Mr. Love has many years of experience in cannabis production in Canada and...

Vancouver, B.C., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Vancouver, B.C., October 23, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2 ) The Company and ABG-HMX, LLC (“ ABG ”) have mutually agreed to an early termination of the license agreement dated June 1, 2018 (the “ License Agreement ”) pursuant to an omnibus settlement and termination agreement (the “ Termination Agreement ”). The Company continues to focus on increasing...

Vancouver, B.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, October 17, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the completion, effective October 16, 2019, of the previously announced sale of all the Company's shares of Future Harvest Development Ltd. (" Future Harvest "), which shares are held by the Company's wholly owned subsidiary Prestige Worldwide Holdings Inc. and comprise 82.5% of...

Vancouver, B.C., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, October 8, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that, due to health complications, Trevor Dixon, President, CEO and Director of the Company, is unable to fulfill his duties to the Company for the time being. Accordingly: (1) the Board has appointed Marc Ripa as Interim CEO; and (2) Mr. Dixon has appointed Brenda Dixon to be his alternate as a Director of...

Vancouver, B.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 24, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company is pleased to announce the completion of the previously announced sale of all of the Company’s shares of 0989561 BC Ltd. dba Canandia Bioceuticals (“ Canandia ”) to a company owned by Alon Amit, Director and Chief Executive Officer of Canandia (the “ Transaction ”) effective September 23,...

Vancouver, B.C., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 20, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces that, the Company has agreed to sell the 82.5% issued and outstanding shares (the “ Future Harvest Shares ”) of Future Harvest Development Ltd. (“ Future Harvest ”) which are held by the Company’s wholly owned subsidiary Prestige Worldwide Holdings Inc. (“ Prestige ”) to SL 152 Ventures...

Vancouver, B.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 11, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to announce that AB Laboratories Inc. (“ AB Labs ”) a company which is a 50% owned subsidiary of Invictus has received their amended license from Health Canada to include the new 40,000 sq. ft. custom built cultivation facility located near Hamilton, Ontario. As previously announced on June 26,...

Vancouver, B.C., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 30, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces that, in accordance with the Company’s plan to reduce operational costs and streamline the Company’s capital expenditures, it has agreed to sell off all the issued and outstanding shares (the “ Canandia Shares ”) of 0989561 BC Ltd. dba Canandia Bioceuticals (“ Canandia ”) to a company owned by...

Vancouver, B.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 27, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. (" Acreage "), the Company's wholly-owned subsidiary, has signed a non-binding term sheet (the " Term Sheet ") for a secured term loan of up to $6.0 million (the “ Loan Amount ”) with an interest rate of 10.0% per annum (the “ Term Loan ”) on drawn amounts with...

Vancouver, B.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that Acreage Pharms Ltd. (“ Acreage” ), the Company’s wholly owned subsidiary, has been awarded an oil sales license by Health Canada. Acreage continues to build an inventory of oils high in CBD, one to one ratio THC to CBD and high THC...

Vancouver, B.C., Aug. 12, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing and branding innovator Gene Simmons has abdicated his position as the Company’s Chief Evangelist Officer. “It has been a pleasure to work with Gene. He has been a valuable asset to the Company,” said Trevor Dixon, President and Chief Executive Officer of Invictus. “Gene has pledged his...

Vancouver, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that Acreage Pharms Ltd. (“ Acreage” ), the Company’s wholly owned subsidiary has substantially completed the construction of the 90,000 square foot Phase III cultivation facility in Edson, Alberta (the “ Facility ”). An amendment to...